Iterative Health Closes $77 Million Series C to Accelerate the Future of Clinical Research

-Iterative Health, a healthcare technology and services company powering the acceleration of clinical research, today announced the close of a $77 million Series C financing round.

Discover Insights and Trends

Iterative Health Closes $77 Million Series C to Accelerate the Future of Clinical Research

VAST Data Valued at $30 Billion as AI Drives a New Infrastructure Stack

Southeast Asian startups total funding surges 110 percent year on year to $2.8B in Q1 – Tracxn

Addepar Expands in Singapore as APAC Demands Reshape Data and AI Workflows

Thai AI startup Amity announces US$100 million Series D funding round; launches R&D centre in Singapore

Beyond Silicon Valley: Why ambition is eastward bound

New R&D facility to build next-generation equipment targeting Singapore-based chip giants

The Moment a New Cancer Treatment Met Its First Patient

Semiconductor firm Ambiq to expand R&D in Singapore, eyes 30 specialised tech hires